LON:BVXP

Bioventix Final Earnings Results & Report

Bioventix logo
GBX 1,896.55 -53.45 (-2.74%)
As of 11/20/2026 11:53 AM Eastern

Bioventix reported Final earnings on October 26, 2026. The company reported EPS of GBX 145.74, while revenue was £12.97 million.

Earnings Announcement Details

Quarter
Final
Report Date
Time
Before Market Opens

Bioventix EPS Results

Actual EPS
GBX 145.74
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Bioventix Revenue Results

Actual Revenue
£12.97 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Conference Call Resources

Bioventix Final Earnings FAQ

Bioventix (LON:BVXP) reported earnings of GBX 145.74 per share for Final. The report was announced on Monday, October 26, 2026.

Bioventix reported revenue of £12.97 million for Final.

Bioventix Earnings Headlines

Bioventix : Posting of Annual Report and Notice of AGM
Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
See More Bioventix Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Bioventix? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bioventix and other key companies, straight to your email.

About Bioventix

Bioventix (LON:BVXP) creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.

View Bioventix Profile